Evidence map›Paper›PMID 35695564›Full record

ArticleMicrobiology spectrum2022

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19.

Tamara Seitz, Johannes Holbik, Julian Hind, Georg Gibas, Mario Karolyi, Erich Pawelka, Marianna Traugott, Christoph Wenisch, Alexander Zoufaly

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Observational
  4. Article
  5. Evaluation of T2 Magnetic Resonance (T2MRAntibiotics (Basel, Switzerland) · 2024
    Article
  6. Point-of-Care Method T2BacteriaMicroorganisms · 2024
    Article
  7. Observational
  8. Article
  9. Unresolved issues in the diagnosis of catheter related candidemia: A position paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tamara SeitzDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.ORCID 0000-0003-0484-2240
Johannes HolbikDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Julian HindDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Georg GibasDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Mario KarolyiDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Erich PawelkaDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Marianna TraugottDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Christoph WenischDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Alexander ZoufalyDepartment of Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A high rate of bacterial and fungal superinfections was reported in critically ill patients with COVID-19. However, diagnosis can be challenging. The aim of this study is to evaluate the sensitivity and the clinical utility of the point-of-care method T2 magnetic resonance (T2MR) with the gold standard: the blood culture. T2MR can potentially detect five different

Indexed as

CandidemiaCOVID-19Enterococcus faeciumSuperinfectionAnti-Bacterial AgentsBlood CultureCandidaEscherichia coliHumansMagnetic Resonance SpectroscopyAnti-Bacterial AgentsbacteremiacandidemiaCOVID-19SARS-COV-2secondary infectionsuperinfection

Identifiers

PMID35695564
PMCPMC9241933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.